He Wang, MD, PhD, Named Director of New Cardiovascular Pathology Section in Pathology
Chen Liu, MD, PhD, Chair of Yale Pathology, announced He (Peter) Wang, MD, PhD, Associate Professor of Pathology, as Director of the newly established Cardiovascular Pathology section in the Department of Pathology at Yale School of Medicine.
Strategies to accelerate diagnosis and treatment of rare cardiovascular diseases
The current landscape for patients with rare cardiovascular disease has shifted. Using genome sequencing Yale physician-scientists have begun to elucidate the pathophysiology of genetic disorders and develop treatment guidelines and recommendations.
Study illuminates tiny RNA’s role in heart disease, obesity
A tiny RNA molecule plays a big role in the development of two diseases affecting billions of people worldwide: heart disease and obesity. Yale researchers have found that by disrupting this microRNA in key tissues, they can reduce plaque buildup in arteries while avoiding unintended effects.
Yale lab finding may protect the heart during ischemia
Research from three Yale laboratories — in the fields of immunobiology, chemistry, and cardiology — could lead to new drugs to reduce complications during cardiac surgery or heart attacks. If they pan out in human trials, the drugs would limit the detrimental impact of ischemia—restriction of blood flow—thereby cutting the degree of damage to the heart. The research appeared in the June online issue of Circulation.
Women more likely than men to have adverse events after AF ablation
Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.Source: Healio
Cytokinetics Announces Upcoming Presentations at the 2022 Inaugural HCM Society Scientific Sessions and the HFSA Annual Scientific Meeting
The Heart Failure Society of America (HFSA) Annual Scientific Meeting will take place in Washington, D.C. from September 30, 2022 to October 3, 2022.Source: Yahoo
Is IVL equally effective in male and female patients? Shockwave Medical aims to find out with a historic new study
Shockwave Medical has announced a new clinical trial focused on the safety and effectiveness of its intravascular lithotripsy (IVL) technology in female patients.Source: Cardiovascular Business